Denali Therapeutics Inc. (DNLI)
NASDAQ · Healthcare
Denali Therapeutics Inc. Shares Outstanding 2016–2025
Denali Therapeutics Inc. annual/quarterly shares outstanding history and growth rate from 2017 to 2024. Shares outstanding refers to a company's stock currently held by all its shareholders, including institutional investors and company insiders.
- Denali Therapeutics Inc. shares outstanding for the quarter ending September 30, 2024 was 0.17 B shs, a 23.11% increase year-over-year.
- Denali Therapeutics Inc. annual shares outstanding for 2025 was 0.17 B shs, a 4.97% increase from 2024.
- Denali Therapeutics Inc. annual shares outstanding for 2024 was 0.16 B shs, a 19.73% increase from 2023.
- Denali Therapeutics Inc. annual shares outstanding for 2023 was 0.14 B shs, a 9.43% increase from 2022.
- Denali Therapeutics Inc. annual shares outstanding for 2022 was 0.13 B shs.
Shares Outstanding
ANNUAL · B SHS
QUARTERLY · B SHS
YEAR-OVER-YEAR GROWTH · %
Denali Therapeutics Inc. Shares Outstanding — FAQ
Denali Therapeutics Inc. (DNLI) shares outstanding over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Denali Therapeutics Inc.'s shares outstanding?
Denali Therapeutics Inc. (DNLI) reported shares outstanding of 0.17B shares for fiscal 2025.
Where can I see DNLI's shares outstanding history?
The chart and table above show Denali Therapeutics Inc.'s shares outstanding by year and by quarter, including the growth rate.